Clinically significant venous thromboembolism after gynecologic surgery

Area of Science:

• Gynecology
• Thromboembolism Research
• Surgical Outcomes

Background:

• Venous thromboembolism (VTE) is a significant risk following gynecologic surgery.
• Understanding VTE incidence and outcomes in this population is crucial for patient safety.
• Provider-specified prophylaxis protocols are widely used.

Purpose of the Study:

• To determine the incidence and outcomes of clinically significant VTE after gynecologic surgery.
• To evaluate VTE occurrence in patients receiving standard prophylaxis.
• To identify risk factors associated with VTE development and complications.

Main Methods:

• Retrospective review of a computerized patient database from 1992-1997.
• Identification of patients with VTE post-gynecologic surgery.
• Exclusion of VTE present preoperatively or diagnosed after 30 days postoperatively.

Main Results:

• VTE incidence was less than 1 event per 500 procedures (>30,000 surgeries).
• 91% of VTE patients received prophylaxis.
• VTE was rare (<1 event in 4,000) in patients with benign disease, short anesthesia, and no prior VTE or Factor V Leiden deficiency.
• 25% of VTE patients experienced anticoagulation complications.

Conclusions:

• Clinically significant VTE is rare in gynecologic surgery patients without malignancy, prolonged anesthesia, or hypercoagulation factors.
• Anticoagulation therapy for VTE in this population frequently results in complications.
• Risk stratification and careful management are essential for VTE prevention and treatment.